Faron Pharmaceuticals Oy (FARN.L) LSE
Currency In GBp
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 222.03M |
| Enterprise Value | 234.39M |
| P/E Ratio | -2.88 |
| PEG Ratio | -1.61 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 4.84 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -3.15 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.46 |
| Return On Equity | 4.76 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -325,893 |
| EBITDA | -19.93M |
| Net Income | -27.25M |
| Diluted EPS | -0.25 |
Balance Sheet
| Total Cash | 32.15M |
| Total Cash/Share | 0.21 |
| Total Debt | 17.92M |
| Total Debt/Equity | 1.54 |
| Current Ratio | 2.4 |
| Book Value Per Share | 0.08 |
Price History
| 52-Week Change | -84.9 |
| 52-Week High | 205 |
| 52-Week Low | 28 |
| Moving Average 50 Days | 34.57 |
| Moving Average 200 Days | 44.3 |
Statistics
| Average Volume | 47,231 |
| Shares Outstanding | 202.88M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 151:125 |
| Last Split Date | June 04, 2024 |
AD
